“Tofacitinib Monotherapy in Rheumatoid Arthritis: Comparative Efficacy in a 12-Month Prospective Cohort Study”, EMSGH, vol. 1, pp. 1–9, Jun. 2025, doi: 10.70267/emsgh.2501.0109.